FTO and obesity due to melanocortin 4 receptor deficiency: Studies have confirmed that FTO levels were positively correlated with obesity, insulin resistance, blood glucose, the risk of complications, and FTO were up-regulated in vessels, liver and skeletal muscles of DM patients and animal models, indicating the FTO-m6A axis could be a potential therapeutic target for diabetic complications [11–13].